[Elsevier] Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy ORIENT-31

bryanphandhy Post time The day before yesterday 02:15 | Show all posts |Read mode
This post will be closed automatically in 2026-10-31 02:15
Reward15points

journalㄩThe Lancet Oncology

AuthorsㄩShun Lu; Lin Wu; Hong Jian; Ying Cheng; Qisen Guo

DOIㄩ10.1016/S1470-2045(22)00382-5

Article linkㄩhttps://doi.org/10.1016/S1470-2045(22)00382-5

RemarkㄩThank you very much!
Reply

Use magic Donate Report

All Reply1 Show all posts
Umarie Post time The day before yesterday 11:06 | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    1115


Return to the list